JG and TB Modifiers explained
CMS has used these modifiers to track 340B-acquired drugs on outpatient claims, with requirements that have changed over time.
Covered entities should follow current CMS instructions on which modifier applies, because requirements have shifted between payment policies.
Where JG and TB Modifiers fits in the revenue cycle
JG and TB Modifiers sits within the coding stage of the revenue cycle. It is a coding modifier, a two-character code appended to a CPT or HCPCS code to add necessary detail about the service performed.
JG and TB Modifiers is also referred to as 340B Drugs. You'll encounter it on payer communications, billing reports, and in conversations between front-office, coding, and accounts-receivable teams.
Why JG and TB Modifiers matters for your practice
Modifiers tell the payer exactly what happened, that a service was distinct, bilateral, reduced, or involved drug waste, for example. The wrong modifier (or a missing one) is a common, highly preventable cause of denials and underpayment, especially in procedure-heavy and drug-billing specialties.
- Appended to CPT/HCPCS codes to clarify the service
- Incorrect or missing modifiers are a top denial driver
- Especially critical in surgery, imaging, and drug billing
- Must align with payer policy and NCCI edits
JG and TB Modifiers in practice
Knowing what JG and TB Modifiers means is only useful if it changes what your team does. In a modern revenue cycle, that means catching issues related to modifiers earlier, documenting and coding them correctly, and using technology to flag exceptions automatically rather than discovering them after a claim is denied.
This is exactly where a specialty-built revenue cycle platform earns its keep: by encoding the rules behind terms like JG and TB Modifiers directly into the workflow, so clean claims go out the first time and your team works by exception instead of chasing problems after the fact.
